Article
Structural identification of a hotspot on CFTR for potentiation
20 Jun 2019
Abstract excerpt
Cystic fibrosis is a fatal disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Two main categories of drugs are being developed: correctors that improve folding of CFTR and potentiators that recover the function of CFTR. Here, we report two cryo-electron microscopy structures of human CFTR in complex with potentiators: one with the U.S. Food and Drug Administration...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
